Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
No open-market purchases or sales by Nuvectis Pharma, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Nuvectis Pharma, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 36 | 40 | +4 |
| Shares | 1.51M | 1.56M | +48.7K (+3.2%) |
| Value | $12.6M | $12.8M | +$187.8K (+1.5%) |
New holders (6)
Institutions that held Nuvectis Pharma, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blue Zone Wealth Advisors, LLC | 14,350 | $117.7K | 0.04% |
| Deutsche Bank AG | 3,509 | $28.8K | 0.00% |
| Trust Co of Vermont | 500 | $4.10K | 0.00% |
| NBC Securities, Inc. | 100 | $1.00K | 0.00% |
| GAMMA Investing LLC | 25 | $205 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 1 | $8 | 0.00% |
Sold out (2)
Institutions that held Nuvectis Pharma, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 25,670 | $214.1K |
| Two Sigma Investments, LP | 22,771 | $189.9K |